NCT06444737View on ClinicalTrials.gov

Contribution of Ondansetron to Preventing Post-Dural Puncture Headaches Following Spinal Anesthesia

NARecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

November 30, 2023

Primary Completion Date

June 30, 2024

Study Completion Date

August 30, 2024

Conditions
Post-Dural Puncture Headache
Interventions
DRUG

Intravenous ondansetron

Intravenous (IV) ondansetron 0.10 mg/ kg diluted in 5 ml normal saline, 5 min before spinal anesthesia

DRUG

Intravenous normal saline

Intravenous normal saline 5 ml (control group) 5 min before spinal anesthesia

Trial Locations (1)

2085

RECRUITING

Mongi slim hospital, Tunis

All Listed Sponsors
lead

Mongi Slim Hospital

OTHER